市場調查報告書

藥物研發服務的全球市場(各種類、流程、醫藥品類型、治療領域):產業展望,綜合分析,未來預測

Drug Discovery Services Market by Type, by Process, by Drug Type, and by Therapeutic Area: Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018-2025

出版商 Zion Market Research 商品編碼 843092
出版日期 內容資訊 英文 110 Pages
商品交期: 2-3個工作天內
價格
藥物研發服務的全球市場(各種類、流程、醫藥品類型、治療領域):產業展望,綜合分析,未來預測 Drug Discovery Services Market by Type, by Process, by Drug Type, and by Therapeutic Area: Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018-2025
出版日期: 2019年02月26日內容資訊: 英文 110 Pages
簡介

本報告提供全球藥物研發服務市場調查,市場及產業概要,各種類、流程、醫藥品類型、治療領域、地區的市場規模的變化與預測,市場成長要素及阻礙因素分析,市場機會,競爭情形,主要企業的簡介等全面性資訊。

第1章 簡介

  • 報告概要與範圍
  • 調查範圍
  • 調查手法

第2章 摘要整理

  • 市場規模的變化與預測(以金額為準)
  • 市場概述

第3章 產業動態

  • 簡介
  • 成長要素
  • 阻礙因素
  • 市場機會
  • 波特的五力分析
  • 市場魅力分析:各市場區隔

第4章 競爭環境

  • 市場佔有率分析
  • 策略趨勢
    • 合併、收購
    • 新材料的登場
    • 協定、夥伴關係、合作、合資企業
    • 研究開發、事業擴大

第5章 藥物研發服務的全球市場:各類型

  • 市場概要
  • 藥物動力學、藥物代謝
  • 生物學服務
  • 醫藥品化學
  • 其他

第6章 藥物研發服務的全球市場:各流程

  • 市場概要
  • 目標鑑定
  • 目標區分
  • 先導藥物探索
  • 目標檢驗
  • 先導藥物最適化

第7章 藥物研發服務的全球市場:各醫藥品類型

  • 市場概要
  • 生物製藥
  • 低分子醫藥品

第8章 藥物研發服務的全球市場:各治療領域

  • 市場概要
  • 神經疾病
  • 糖尿病
  • 癌症、腫瘤
  • 呼吸疾病
  • 心血管疾病
  • 其他

第9章 藥物研發服務的全球市場:各地區

  • 市場概要
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東、非洲

第10章 企業簡介

  • Albany Molecular Research Inc.
  • Thermo Fisher Scientific
  • Biogen
  • Evotec
  • Charles River Laboratories International
  • Domainex
  • Covance
  • Selcia Limited
  • WuXiAppTec
  • Viva Biotech
  • Pharmaceutical Product Development, LLC
  • SRI International
目錄

The report covers a forecast and an analysis of the drug discovery services market on a global and regional level. The study provides historical data for 2016, 2017, and 2018 along with a forecast from 2019 to 2025 based on revenue (USD Billion). The study includes drivers and restraints of the drug discovery services market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the drug discovery services market on a global and regional level.

In order to give the users of this report a comprehensive view of the drug discovery services market, we have included competitive landscape and analysis of Porters Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

The report provides company market share analysis to give a broader overview of the key players in the drug discovery services market. In addition, the report also covers key strategic developments of the market including acquisitions mergers, new product launch, agreements, partnerships, collaborations joint ventures, research development, and regional expansion of major participants involved in the drug discovery services market on a global and regional basis.

The study provides a decisive view of the drug discovery services market by segmenting the market based on type, process, drug type, therapeutic area, and region. By type, the drug discovery services market is segmented into pharmacokinetics and drug metabolism, biology services, and medicinal chemistry. The process segment includes target validation, target selection, hit-to-lead identification, candidate validation, and lead optimization. The drug type segment includes biologics and small molecules. The therapeutic area segment includes neurology, diabetes, oncology, respiratory diseases, cardiovascular diseases, and others.

The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further segmentation into major countries including the U.S., Germany, France, UK, China, Japan, India, and Brazil.

Some key players of the global drug discovery services market are Albany Molecular Research Inc. (AMRI), Thermo Fisher Scientific, Evotec, Charles River Laboratories International, Domainex, Covance, GenScript, Selcia Limited, WuXiAppTec, Viva Biotech, Pharmaceutical Product Development, LLC, and SRI International, among others.

This report segments the global drug discovery services market into:

Global Drug Discovery Services Market: By Type

  • Pharmacokinetics and Drug Metabolism
  • Biology Services
  • Medicinal Chemistry

Global Drug Discovery Services Market: By Process

  • Target Validation
  • Target Selection
  • Hit-To-Lead Identification
  • Candidate Validation
  • Lead Optimization

Global Drug Discovery Services Market: By Drug Type

  • Biologics
  • Small Molecules

Global Drug Discovery Services Market: By Therapeutic Area

  • Neurology
  • Diabetes
  • Oncology
  • Respiratory Diseases
  • Cardiovascular Diseases
  • Others

Global Drug Discovery Services Market: By Region

  • North America
  • The U.S.
  • Europe
  • UK
  • France
  • Germany
  • Asia Pacific
  • China
  • Japan
  • India
  • Latin America
  • Brazil
  • Middle East and Africa

Table Of Contents

Chapter 1. Introduction

  • 1.1. Report description and scope
  • 1.2. Research scope
  • 1.3. Research methodology
    • 1.3.1. Market research process
    • 1.3.2. Market research methodology

Chapter 2. Executive Summary

  • 2.1. Global Drug Discovery Services market, 2018-2025(USD Billion)
  • 2.2. Global Drug Discovery Services market: Snapshot

Chapter 3. Drug Discovery Services Market - Industry Dynamics

  • 3.1. Introduction
  • 3.2. Market drivers
    • 3.2.1. Rising expenditure on research and development
    • 3.2.2. Growing inclination of pharmaceutical companies toward outsourcing to evade hurdles
  • 3.3. Market Restraints
    • 3.3.1. High costs of drug discovery
    • 3.3.2. Strict guidelines in some regions
  • 3.4. Opportunities
    • 3.4.1. Patent expiry of current products
    • 3.4.2. Technological improvements in drug discovery services
  • 3.5. Porter's Five Forces analysis
    • 3.5.1. Bargaining power of suppliers
    • 3.5.2. Bargaining power of buyers
    • 3.5.3. The threat from new entrants
    • 3.5.4. The threat from new substitutes
    • 3.5.5. Degree of competition
  • 3.6. Market attractiveness analysis
    • 3.6.1. Market attractiveness analysis, by Type
    • 3.6.2. Market attractiveness analysis, by Process
    • 3.6.3. Market attractiveness analysis, by Drug Type
    • 3.6.4. Market attractiveness analysis, by Therapeutic Area

Chapter 4. Global Drug Discovery Services Market - Competitive Landscape

  • 4.1. Company Market Share Analysis
    • 4.1.1. Global Drug Discovery Services market: company market share, 2018
  • 4.2. Strategic Development
    • 4.2.1. Acquisitions & Mergers
    • 4.2.2. New Product Launch
    • 4.2.3. Agreements, Partnerships, Collaborations, and Joint Ventures
    • 4.2.4. Research and Development and Regional Expansion

Chapter 5. Global Drug Discovery Services Market - Type Analysis

  • 5.1. Global Drug Discovery Services market: Type overview
    • 5.1.1. Global Drug Discovery Services market revenue share, by Type, 2018 and 2025
  • 5.2. Pharmacokinetics and Drug Metabolism
    • 5.2.1. Global Drug Discovery Services market for Pharmacokinetics and Drug Metabolism, 2016-2025 (USD Billion)
  • 5.3. Biology Services
    • 5.3.1. Global Drug Discovery Services market for Biology Services, 2016-2025 (USD Billion)
  • 5.4. Medicinal Chemistry
    • 5.4.1. Global Drug Discovery Services market for Medicinal Chemistry, 2016-2025 (USD Billion)

Chapter 6. Global Drug Discovery Services Market - Process Analysis

  • 6.1. Global Drug Discovery Services market: Process overview
    • 6.1.1. Global Drug Discovery Services market revenue share, by Process, 2018 and 2025
  • 6.2. Target Validation
    • 6.2.1. Global Drug Discovery Services market for Target Validation, 2016-2025 (USD Billion)
  • 6.3. Target Selection
    • 6.3.1. Global Drug Discovery Services market for Target Selection, 2016-2025 (USD Billion)
  • 6.4. Hit-to-lead Identification
    • 6.4.1. Global Drug Discovery Services market for Hit-to-lead Identification, 2016-2025 (USD Billion)
  • 6.5. Candidate Validation
    • 6.5.1. Global Drug Discovery Services market for Candidate Validation, 2016-2025 (USD Billion)
  • 6.6. Lead Optimization
    • 6.6.1. Global Drug Discovery Services market for Lead Optimization, 2016-2025 (USD Billion)

Chapter 7. Global Drug Discovery Services Market - Drug Type Analysis

  • 7.1. Global Drug Discovery Services market: Drug Type overview
    • 7.1.1. Global Drug Discovery Services market revenue share, by Drug Type, 2018 and 2025
  • 7.2. Biologics
    • 7.2.1. Global Drug Discovery Services market for Biologics, 2016-2025 (USD Billion)
  • 7.3. Small Molecules
    • 7.3.1. Global Drug Discovery Services market for Small Molecules, 2016-2025 (USD Billion)

Chapter 8. Global Drug Discovery Services Market - Therapeutic Area Analysis

  • 8.1. Global Drug Discovery Services market: Therapeutic Area overview
    • 8.1.1. Global Drug Discovery Services market revenue share, by Therapeutic Area, 2018 and 2025
  • 8.2. Neurology
    • 8.2.1. Global Drug Discovery Services market for Neurology, 2016-2025 (USD Billion)
  • 8.3. Diabetes
    • 8.3.1. Global Drug Discovery Services market for Diabetes, 2016-2025 (USD Billion)
  • 8.4. Oncology
    • 8.4.1. Global Drug Discovery Services market for Oncology, 2016-2025 (USD Billion)
  • 8.5. Respiratory Diseases
    • 8.5.1. Global Drug Discovery Services market for Respiratory Diseases, 2016-2025 (USD Billion)
  • 8.6. Cardiovascular Diseases
    • 8.6.1. Global Drug Discovery Services market for Cardiovascular Diseases, 2016-2025 (USD Billion)
  • 8.7. Others
    • 8.7.1. Global Drug Discovery Services market for Others, 2016-2025 (USD Billion)

Chapter 9. Global Drug Discovery Services Market - Regional Analysis

  • 9.1. Global Drug Discovery Services market: Regional overview
    • 9.1.1. Global Drug Discovery Services market revenue share, by region, 2018 and 2025
  • 9.2. North America
    • 9.2.1. North America Drug Discovery Services market revenue, by Type, 2016-2025 (USD Billion)
    • 9.2.2. North America Drug Discovery Services market revenue, by Process, 2016-2025 (USD Billion)
    • 9.2.3. North America Drug Discovery Services market revenue, by Drug Type, 2016-2025 (USD Billion)
    • 9.2.4. North America Drug Discovery Services market revenue, by Therapeutic Area, 2016-2025 (USD Billion)
    • 9.2.5. The U.S.
      • 9.2.5.1. The U.S. Drug Discovery Services market revenue, by Type, 2016-2025 (USD Billion)
      • 9.2.5.2. The U.S. Drug Discovery Services market revenue, by Process, 2016-2025 (USD Billion)
      • 9.2.5.3. The U.S. Drug Discovery Services market revenue, by Drug Type, 2016-2025 (USD Billion)
      • 9.2.5.4. The U.S. Drug Discovery Services market revenue, by Therapeutic Area, 2016-2025 (USD Billion)
    • 9.2.6. Rest of North America
      • 9.2.6.1. Rest of North America Drug Discovery Services market revenue, by Type, 2016-2025 (USD Billion)
      • 9.2.6.2. Rest of North America Drug Discovery Services market revenue, by Process, 2016-2025 (USD Billion)
      • 9.2.6.3. Rest of North America Drug Discovery Services market revenue, by Drug Type, 2016-2025 (USD Billion)
      • 9.2.6.4. Rest of North America Drug Discovery Services market revenue, by Therapeutic Area, 2016-2025 (USD Billion)
  • 9.3. Europe
    • 9.3.1. Europe Drug Discovery Services market revenue, by Type, 2016-2025 (USD Billion)
    • 9.3.2. Europe Drug Discovery Services market revenue, by Process, 2016-2025 (USD Billion)
    • 9.3.3. Europe Drug Discovery Services market revenue, by Drug Type, 2016-2025 (USD Billion)
    • 9.3.4. Europe Drug Discovery Services market revenue, by Therapeutic Area, 2016-2025 (USD Billion)
    • 9.3.5. Germany
      • 9.3.5.1. Germany Drug Discovery Services market revenue, by Type, 2016-2025 (USD Billion)
      • 9.3.5.2. Germany Drug Discovery Services market revenue, by Process, 2016-2025 (USD Billion)
      • 9.3.5.3. Germany Drug Discovery Services market revenue, by Drug Type, 2016-2025 (USD Billion)
      • 9.3.5.4. Germany Drug Discovery Services market revenue, by Therapeutic Area, 2016-2025 (USD Billion)
    • 9.3.6. UK
      • 9.3.6.1. UK Drug Discovery Services market revenue, by Type, 2016-2025 (USD Billion)
      • 9.3.6.2. UK Drug Discovery Services market revenue, by Process, 2016-2025 (USD Billion)
      • 9.3.6.3. UK Drug Discovery Services market revenue, by Drug Type, 2016-2025 (USD Billion)
      • 9.3.6.4. UK Drug Discovery Services market revenue, by Therapeutic Area, 2016-2025 (USD Billion)
    • 9.3.7. France
      • 9.3.7.1. France Drug Discovery Services market revenue, by Type, 2016-2025 (USD Billion)
      • 9.3.7.2. France Drug Discovery Services market revenue, by Process, 2016-2025 (USD Billion)
      • 9.3.7.3. France Drug Discovery Services market revenue, by Drug Type, 2016-2025 (USD Billion)
      • 9.3.7.4. France Drug Discovery Services market revenue, by Therapeutic Area, 2016-2025 (USD Billion)
    • 9.3.8. Rest of Europe
      • 9.3.8.1. Rest of Europe Drug Discovery Services market revenue, by Type, 2016-2025 (USD Billion)
      • 9.3.8.2. Rest of Europe Drug Discovery Services market revenue, by Process, 2016-2025 (USD Billion)
      • 9.3.8.3. Rest of Europe Drug Discovery Services market revenue, by Drug Type, 2016-2025 (USD Billion)
      • 9.3.8.4. Rest of Europe Drug Discovery Services market revenue, by Therapeutic Area, 2016-2025 (USD Billion)
  • 9.4. Asia Pacific
    • 9.4.1. Asia Pacific Drug Discovery Services market revenue, by Type, 2016-2025 (USD Billion)
    • 9.4.2. Asia Pacific Drug Discovery Services market revenue, by Process, 2016-2025 (USD Billion)
    • 9.4.3. Asia Pacific Drug Discovery Services market revenue, by Drug Type, 2016-2025 (USD Billion)
    • 9.4.4. Asia Pacific Drug Discovery Services market revenue, by Therapeutic Area, 2016-2025 (USD Billion)
    • 9.4.5. China
      • 9.4.5.1. China Drug Discovery Services market revenue, by Type, 2016-2025 (USD Billion)
      • 9.4.5.2. China Drug Discovery Services market revenue, by Process, 2016-2025 (USD Billion)
      • 9.4.5.3. China Drug Discovery Services market revenue, by Drug Type, 2016-2025 (USD Billion)
      • 9.4.5.4. China Drug Discovery Services market revenue, by Therapeutic Area, 2016-2025 (USD Billion)
    • 9.4.6. Japan
      • 9.4.6.1. Japan Drug Discovery Services market revenue, by Type, 2016-2025 (USD Billion)
      • 9.4.6.2. Japan Drug Discovery Services market revenue, by Process, 2016-2025 (USD Billion)
      • 9.4.6.3. Japan Drug Discovery Services market revenue, by Drug Type, 2016-2025 (USD Billion)
      • 9.4.6.4. Japan Drug Discovery Services market revenue, by Therapeutic Area, 2016-2025 (USD Billion)
    • 9.4.7. India
      • 9.4.7.1. India Drug Discovery Services market revenue, by Type, 2016-2025 (USD Billion)
      • 9.4.7.2. India Drug Discovery Services market revenue, by Process, 2016-2025 (USD Billion)
      • 9.4.7.3. India Drug Discovery Services market revenue, by Drug Type, 2016-2025 (USD Billion)
      • 9.4.7.4. India Drug Discovery Services market revenue, by Therapeutic Area, 2016-2025 (USD Billion)
    • 9.4.8. Rest of Asia Pacific
      • 9.4.8.1. Rest of Asia Pacific Drug Discovery Services market revenue, by Type, 2016-2025 (USD Billion)
      • 9.4.8.2. Rest of Asia Pacific Drug Discovery Services market revenue, by Process, 2016-2025 (USD Billion)
      • 9.4.8.3. Rest of Asia Pacific Drug Discovery Services market revenue, by Drug Type, 2016-2025 (USD Billion)
      • 9.4.8.4. Rest of Asia Pacific Drug Discovery Services market revenue, by Therapeutic Area, 2016-2025 (USD Billion)
  • 9.5. Latin America
    • 9.5.1. Latin America Drug Discovery Services market revenue, by Type, 2016-2025 (USD Billion)
    • 9.5.2. Latin America Drug Discovery Services market revenue, by Process, 2016-2025 (USD Billion)
    • 9.5.3. Latin America Drug Discovery Services market revenue, by Drug Type, 2016-2025 (USD Billion)
    • 9.5.4. Latin America Drug Discovery Services market revenue, by Therapeutic Area, 2016-2025 (USD Billion)
    • 9.5.5. Brazil
      • 9.5.5.1. Brazil Drug Discovery Services market revenue, by Type, 2016-2025 (USD Billion)
      • 9.5.5.2. Brazil Drug Discovery Services market revenue, by Process, 2016-2025 (USD Billion)
      • 9.5.5.3. Brazil Drug Discovery Services market revenue, by Drug Type, 2016-2025 (USD Billion)
      • 9.5.5.4. Brazil Drug Discovery Services market revenue, by Therapeutic Area, 2016-2025 (USD Billion)
    • 9.5.6. Rest of Latin America
      • 9.5.6.1. Rest of Latin America Drug Discovery Services market revenue, by Type, 2016-2025 (USD Billion)
      • 9.5.6.2. Rest of Latin America Drug Discovery Services market revenue, by Process, 2016-2025 (USD Billion)
      • 9.5.6.3. Rest of Latin America Drug Discovery Services market revenue, by Drug Type, 2016-2025 (USD Billion)
      • 9.5.6.4. Rest of Latin America Drug Discovery Services market revenue, by Therapeutic Area, 2016-2025 (USD Billion)
  • 9.6. The Middle East and Africa
    • 9.6.1. The Middle East and Africa Drug Discovery Services market revenue, by Type, 2016-2025 (USD Billion)
    • 9.6.2. The Middle East and Africa Drug Discovery Services market revenue, by Process, 2016-2025 (USD Billion)
    • 9.6.3. The Middle East and Africa Drug Discovery Services market revenue, by Drug Type, 2016-2025 (USD Billion)
    • 9.6.4. The Middle East and Africa Drug Discovery Services market revenue, by Therapeutic Area, 2016-2025 (USD Billion)

Chapter 10. Company Profile

  • 10.1. Albany Molecular Research Inc. (AMRI)
    • 10.1.1. Overview
    • 10.1.2. Financials
    • 10.1.3. Drug Type portfolio
    • 10.1.4. Business strategy
    • 10.1.5. Recent developments
  • 10.2. Thermo Fisher Scientific
    • 10.2.1. Overview
    • 10.2.2. Financials
    • 10.2.3. Drug Type portfolio
    • 10.2.4. Business strategy
    • 10.2.5. Recent developments
  • 10.3. Biogen
    • 10.3.1. Overview
    • 10.3.2. Financials
    • 10.3.3. Drug Type portfolio
    • 10.3.4. Business strategy
    • 10.3.5. Recent developments
  • 10.4. Evotec
    • 10.4.1. Overview
    • 10.4.2. Financials
    • 10.4.3. Drug Type portfolio
    • 10.4.4. Business strategy
    • 10.4.5. Recent developments
  • 10.5. Charles River Laboratories International
    • 10.5.1. Overview
    • 10.5.2. Financials
    • 10.5.3. Drug Type portfolio
    • 10.5.4. Business strategy
    • 10.5.5. Recent developments
  • 10.6. Domainex
    • 10.6.1. Overview
    • 10.6.2. Financials
    • 10.6.3. Drug Type portfolio
    • 10.6.4. Business strategy
    • 10.6.5. Recent developments
  • 10.7. Covance
    • 10.7.1. Overview
    • 10.7.2. Financials
    • 10.7.3. Drug Type portfolio
    • 10.7.4. Business strategy
    • 10.7.5. Recent developments
  • 10.8. GenScript
    • 10.8.1. Overview
    • 10.8.2. Financials
    • 10.8.3. Drug Type portfolio
    • 10.8.4. Business strategy
    • 10.8.5. Recent developments
  • 10.9. Selcia Limited
    • 10.9.1. Overview
    • 10.9.2. Financials
    • 10.9.3. Drug Type portfolio
    • 10.9.4. Business strategy
    • 10.9.5. Recent developments
  • 10.10. WuXiAppTec
    • 10.10.1. Overview
    • 10.10.2. Financials
    • 10.10.3. Drug Type portfolio
    • 10.10.4. Business strategy
    • 10.10.5. Recent developments
  • 10.11. Viva Biotech
    • 10.11.1. Overview
    • 10.11.2. Financials
    • 10.11.3. Drug Type portfolio
    • 10.11.4. Business strategy
    • 10.11.5. Recent developments
  • 10.12. Pharmaceutical Product Development, LLC
    • 10.12.1. Overview
    • 10.12.2. Financials
    • 10.12.3. Drug Type portfolio
    • 10.12.4. Business strategy
    • 10.12.5. Recent developments
  • 10.13. SRI International
    • 10.13.1. Overview
    • 10.13.2. Financials
    • 10.13.3. Drug Type portfolio
    • 10.13.4. Business strategy
    • 10.13.5. Recent developments